GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Fenrile Malataur
Country: Bermuda
Language: English (Spanish)
Genre: Health and Food
Published (Last): 6 September 2012
Pages: 181
PDF File Size: 20.28 Mb
ePub File Size: 17.53 Mb
ISBN: 844-5-90991-769-9
Downloads: 11502
Price: Free* [*Free Regsitration Required]
Uploader: Nikobar

Pharmacovigilance could help to prevent these two types of DRPs, not only through identification but also by helping in their solution; on the other hand, interactions and the wrong administration of the medication were problems that presented but that can be prevented with continuous education, unlike those personal characteristics that are individual factors, but can be mentioned to patients so that they will take them into account in the future, in order to prevent new NOMS.

The main reasons for this are:. Resultados negativos asociados al uso de medicamentos que motivan ingreso hospitalario. Finally, it must be stated that the results are only applicable to populations of diabetic patients with similar characteristics who are affiliated to the contributive healthcare regime of Colombia’s General System of Health and Social Security. Phone calls and visits were also made every four months to inquire about hospitalizations, visits to the general physician, specialist, and emergency services.

This shows that the work by the Pharmacist is as important as that of any other health professional; they will not only be in charge of the adequate storage and preparation of medications, but will also contribute to meeting their target objectives with the lowest risk possible, as described by Ohnishi et al.

Some treating physicians do not follow the guidelines for treatment of diabetes mellitus and do not make opportune requests for paraclinical and medical exams necessary for the complete analysis in pharmacotherapeutical monitoring. Pharmacists offered recommendations to physicians, particularly regarding changes in erythropoietin doses and the administration of iron preparations.

Problemas de proceso y resultado relacionados con los medicamentos: The highest prescription was for Group C, Cardiovascular System, with medications; this means that patients with CKD are administered a higher number of medications acting upon this physiological system. It is a useful tool for contributing to the adequate use of medications and guaranteeing their safe, effective, and economic use.

In Barranquilla, the prevalence of CKD is of approximately 46 persons perinhabitants 1. Very frequently, the medical histories do not contain sufficient and necessary information for the case analysis in pharmacotherapeutical monitoring, given that many patients are seen by hired specialists, who generate reports different from those in the medical chart at the EPS, and access to this information is difficult in spite of multiple requests.

  CONTROLLI AUTOMATICI MARRO PDF

El cociente medio del costo por paciente en el grupo control fue 1. The medications with one single case were clobazam, ceftriaxone and dexamethasone.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

The likelihood of adverse effects was the main reason for NOM presentation. The patients selected were notified by phone for their participation in the study; they were then summoned to be furnished the detais of their participation and to sign an informed consent form once they accepted to participate in the study.

Cost of diabetes mellitus in Spain. Riesgo cardiovascular asociado a la insuficiencia renal. Glycemic control and type 2 diabetes mellitus: Parametric and non-parametric hypotheses tests were run for related samples, comparing the initial and final glycated hemoglobin within the same groups. Am J Hosp Pharm. The loss of Within PCP, we must highlight the identification, prevention and solution of Negative Outcomes associated with Medication NOMswhich are considered events that can affect patient health due to the use of medications 9 – 11 ; and all this is caused by the presence of one or more Drug-Related Problems DRPswhich are circumstances or events that lead or can lead to the development of a NOM.

There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients. Diabetes trends in Latin America. The need to schedule home visits requiring greater investment of time when the patient’s health status does not permit attending the healthcare facility.

To reduce health complications and costs in healthcare systems, strategies have been sought to contribute to such aims and which directly involve the pharmacist through a pharmaceutical care program, developed by Hepler and Strand in 8 ; farmacoterapeutido objective is the optimization of the clinical farmacotera;eutico of the drug therapy, improvement of patient quality of life, contribution to the rational use of medications, and detection, prevention, and solution to Negative Outcomes Associated with Medication NOM 9 Solution of negative outcomes associated with medication.

The study had a sample of patients 64 intervened and 79 controls with female predominance Through an interview and evaluation of medical records, we obtained information about antidiabetic medications used, doses, other medications, along with Hemoglobin A1c level, arterial pressure, serum low-density lipoprotein cholesterol level, nephropathy screening, retinal screening, foot exams in the last year and problems associated with medication use by means of the DADER method Negative Outcomes Associated with Medication NOM.

Each of the patients had a replacement selected randomly and with the same characteristics. The descriptive analysis revealed the following: Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: Besides, in our study, there were more reports for Quantitative Ineffectiveness; the reason for this was the lack of modification in treatment dosing, even when this was allowed by the therapeutic window of drugs.

  22TCN 263 PDF

In order to ensure patient safety as a component of quality of care 7Pharmaceutical Care Practice PCP must be conducted as a clinical activity within Pharmaceutical Care PCwith the objective of reducing the morbimortality associated with the use of medications, through activities performed by the Pharmacist, who will be responsible for identifying the needs of the patient regarding pharmacological treatment, with the aim to achieve results that will improve the quality of life of patients, working together with the healthcare team in order to make decisions about the treatment initiated, to ensure its safety and efficacy 8.

La HbA1c inicial tuvo un promedio de 7. Like a snake in the grass. The mean cost per patient in controls was 1. When comparing initial and final HbA1c values of the study, the average for the intervention group was 7.

Glucose intolerance in Colombia. In total, 12 dose re-adjustments were conducted, and 10 of these were accepted. The most prevalent co-morbidities were hypertension, dislipidemia, and hypothyroidism and the most frequent long-term complications can be seen in Table 2.

Effectiveness the pharmaceutical care in diabetic patients* | Machado -Alba | Colombia Médica

Therefore, it is necessary to involve all healthcare professionals and patients, in order to obtain as a result a better use of medications, to prevent NOMs, and to reduce the morbidity associated with drug therapy. Those with a lower proportion were: March 10, ; Accepted: Using the random number table method, we assigned the groups in random and stratified manner; in the intervention group, who had pharmacotherapeutic monitoring for 18 months; and in the control group, who were merely interviewed at the beginning and at the end of the study.

All this based on good communication and cooperation between the patient and health personnel 9. A study was developed to permit determining the efficacy of pharmacotherapeutic monitoring and NOM identification to improve metabolic control by reducing glycated hemoglobin HbA1c in patients with type 2 diabetes mellitus in two Colombian cities when comparing the usual care.

Effectiveness NOMs were reviewed on the basis of the doses used and patient evolution, and Safety NOMs were detected through a comprehensive search in the Clinical Record about the presence of any ADE Adverse Drug Event by analyzing the different treatments, identifying any potential drug interactions, a subsequent pharmaceutical interview, and the evolution of their health situation. Soobre total of 41 pharmaceutical interventions were conducted, 35 were accepted seguiimiento 6 were not accepted.

The intervention was not accepted seguimoento the health problem was solved in 8 cases during the initial visit 4. During the study, the patients were visited on at least three instances, establishing the NOMs in each visit.